Publication Name	World Journal of Cardiology
Manuscript ID	78704
Country	Croatia

Received	2022-07-10 22:35
Peer-Review Started	2022-07-10 22:36
To Make the First Decision
Return for Revision	2022-08-22 00:59
Revised	2022-08-29 23:48
Second Decision	2022-09-20 03:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-09-21 22:30
Articles in Press	2022-09-21 22:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-10-13 09:18
Publish the Manuscript Online	2022-10-20 02:09

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Letter to the Editor
Article Title	Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors
Manuscript Source	Unsolicited Manuscript
All Author List	Nenad Lakušić, Ivana Sopek Merkaš, Ana Marija Slišković and Dora Cerovec
ORCID	Author(s) ORCID Number Nenad Lakušić http://orcid.org/0000-0002-2329-2582 Ivana Sopek Merkaš http://orcid.org/0000-0002-0888-5005 Ana Marija Slišković http://orcid.org/0000-0001-6622-7572 Dora Cerovec http://orcid.org/0000-0002-9014-9866
Funding Agency and Grant Number
Corresponding Author	Ivana Sopek Merkaš, MD, Doctor, Department of Cardiology, Special Hospital for Medical Rehabilitation Krapinske Toplice, 2 Gajeva, Krapinske Toplice 49217, Croatia. ivana.sopek@sbkt.hr
Key Words	Sodium-glucose co-transporter 2 inhibitors; Euglycemic diabetic ketoacidosis; Chronic heart failure
Core Tip	Sodium-glucose co-transporter 2 inhibitors have recently become an established treatment for most chronic heart failure (CHF) patients (with and without diabetes), and it is important for the cardiologist to know their side effects, including those that are rare, but serious, like euglycemic ketoacidosis. In this way, an unwanted outcome of CHF treatment can be avoided.
Publish Date	2022-10-20 02:09
Citation	Lakušić N, Sopek Merkaš I, Slišković AM, Cerovec D. Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors World J Cardiol 2022; 14(10): 561-564
URL	https://www.wjgnet.com/1949-8462/full/v14/i10/561.htm
DOI	https://dx.doi.org/10.4330/wjc.v14.i10.561

Full Article (PDF)	WJC-14-561.pdf
Full Article (Word)	WJC-14-561.docx
Manuscript File	78704_Auto_Edited-LM.docx
Answering Reviewers	78704-Answering reviewers.pdf
Audio Core Tip	78704-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	78704-Conflict-of-interest statement.pdf
Copyright License Agreement	78704-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	78704-Language certificate.pdf
Peer-review Report	78704-Peer-review(s).pdf
Scientific Misconduct Check	78704-Bing-Chen YL-2.png
Scientific Editor Work List	78704-Scientific editor work list.pdf